CHURCHILL: A Comprehensive Analysis Pipeline for the Discovery of Human Genetic Variation

Next Generation Sequencing (NGS) is a sequencing technology characterized by the large volume of generated DNA/RNA sequencing data. However, the cost to analyze NGS data is outstripping the cost to actually produce the data. To circumvent this challenge, the Institute for Genomics Medicine have developed a fully automated and comprehensive analysis tool called CHURCHILL. CHURCHILL’s patented novel parallelization strategy analyzes raw NGS data in a record time.

Patents

Patent # Title Country
9,552,458 Comprehensive Analysis Pipeline for Discovery of Human Genetic Variation United States of America

Loading icon